Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000466946 | SCV000558487 | benign | Brugada syndrome | 2024-11-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000613459 | SCV000730433 | benign | not specified | 2017-11-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Mendelics | RCV000987249 | SCV001136499 | likely benign | Brugada syndrome 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002341091 | SCV002644022 | likely benign | Cardiovascular phenotype | 2019-04-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002496819 | SCV002811878 | likely benign | Episodic pain syndrome, familial, 2 | 2021-07-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003431025 | SCV004154202 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | SCN10A: PP3, BS1, BS2 |
NIHR Bioresource Rare Diseases, |
RCV002254167 | SCV001162080 | likely pathogenic | Impaired temperature sensation | no assertion criteria provided | research |